Volume is critical when collecting umbilical cord blood for transplants, regenerative research

Article

Cerebral palsy, Type 1 diabetes, autism - mounting evidence reveals umbilical cord blood’s promise as an effective treatment for these disorders and a host of others.

However, most umbilical cord blood units fall short of volume to produce optimal patient outcomes. Partially the result of delayed clamping and cutting of the umbilical cord, it's a persistent supply problem that only OB/GYNs and delivery room staff can help solve.

This supplement examines how the issue can be addressed both clinically and in conversation with parents.

Download Supplement

 

Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.